AKT1 and thyroid cancer: We therefore hypothesize that the combination of Vitamin C and PLX4032 may synergistically induce the death of BRAFMT thyroid cancer cell by relieving the feedback activation of MAPK/ERK as well as PI3K/AKT pathways.